CAPITOL HILL CONSULTING GROUP

Lobbying for PURDUE PHARMA LLP

Filing 4th Quarter - Termination

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $50,000.00 income · posted Jan 20, 2026

Lobbying activity 2

Health Issues

Monitoring for issues and hearing related to prevention of abuse, misuse or diversion of prescription drugs; prescription drug payment reform; and pharmaceutical supply chain.

Bankruptcy

Monitored congressional efforts around the SACKLER Act.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.